Yıl: 2019 Cilt: 35 Sayı: 1 Sayfa Aralığı: 28 - 35 Metin Dili: İngilizce DOI: 10.5146/tjpath.2018.01443 İndeks Tarihi: 06-05-2019

Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant

Öz:
Objective: The microscopic and macroscopic features of the placenta can contribute to the clinical understanding of premature delivery. The aim of our study was to figure out the relationship between the histopathological findings of the placentas of premature deliveries and its effects on neonatal morbidity and mortality. Material and Method: The placentas of 284 singleton preterm infants with <35 weeks of gestation were examined. Three groups were created as the normal, chorioamnionitis and vasculopathy groups according to the histopathological findings in the placentas of the subjects. Results: The mean gestational age of the infants in the study group was 30.5 ± 3.2 weeks, and the mean birth weight was 1588 ± 581 g. The pathology was normal in ninety-six (33.8%), vasculopathy in 153 (53.9%) and chorioamnionitis in 35 (12.3%). The gestation age of the infants was lower in the chorioamnionitis group. Moreover, retinopathy of prematurity, early onset neonatal sepsis, and duration of respiratory support were found to be higher in the chorioamnionitis group. In the vasculopathy group, preeclampsia and small for gestational age were found to be significantly higher. Conclusion: Histopathological findings of the placentas from preterm deliveries provided important data in determining the etiology of preterm delivery and outcomes of infants. Infants delivered by mothers with chorioamnionitis were particularly found to be more preterm, and these preterm infants would have a longer hospital stay, higher respiratory support requirement, and more serious morbidities.
Anahtar Kelime: Chorioamnionitis Neonatal morbidity Placental pathology Prematurity Vasculopathy

Konular: Patoloji Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Altuncu E, Akman I, Kotiloglu E, Basgul A, Yurdakul Z, Demir F, Kavak Z, Bas E, Bozkurt N, Bilgen H, et al. The relationship of placental histology to pregnancy and neonatal characteristics in preterm infants. J Turkish-German Gynecol Assoc. 2008;9:1-7.
  • 2. Perrone S, Toti P, Toti MS, Badii S, Becucci E, Gatti MG, Marzocchi B, Picardi A, Buonocore G. Perinatal outcome and placental histological characteristics: A single-center study. J Matern Fetal Neonatal Med. 2012;1:110-3.
  • 3. Roescher AM, Timmer A, Erwich JJ, Bos AF. Placental pathology, perinatal death, neonatal outcome, and neurological development: A systematic review. PLoS One. 2014;9:e89419.
  • 4. Korteweg FJ, Erwich JJ, Holm JP, Ravisé JM, van der Meer J, Veeger NJ, Timmer A. Diverse placental pathologies as the main causes of fetal death. Obstet Gynecol. 2009;114:809-17
  • 5. Hodyl NA, Aboustate N, Bianco-Miotto T, Roberts CT, Clifton VL, Stark MJ. Child neurodevelopmental outcomes following preterm and term birth: What can the placenta tell us? Placenta. 2017;57:79-86.
  • 6. Redline RW. Classification of placental lesions. Am J Obstet Gynecol. 2015;213:S21-8.
  • 7. Leal YA, Álvarez-Nemegyei J, Lavadores-May AI, Girón-Carrillo JL, Cedillo-Rivera R, Velazquez JR. Cytokine profile as diagnostic and prognostic factor in neonatal sepsis. J Matern Fetal Neonatal Med. 2018:1-7.
  • 8. Dargaville PA, Gerber A, Johansson S, De Paoli AG, Kamlin CO, Orsini F, Davis PG; Australian and New Zealand Neonatal Network. Incidence and outcome of CPAP failure in preterm infants. Pediatrics. 2016;138(1). pii: e20153985.
  • 9. Prescott S, Keim-Malpass J. Patent ductus arteriosus in the preterm infant: Diagnostic and treatment options. Adv Neonatal Care. 2017;17:10-18.
  • 10. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20:9-14.
  • 11. American Diabetes Association. Standards of medical care in Diabetes-2014. Diabetes Care. 2014;37 Suppl 1:S14-80.
  • 12. Ogunyemi D, Murillo M, Jackson U, Hunter N, Alperson B. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med. 2003;13:102-9.
  • 13. Lubchencho LO, Hansman C, Dressler M. Intrauterine growth as estimated from live birth-weight data at 24 to 42 weeks of gestation. Pediatrics. 1963;32:793-800.
  • 14. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276:357-68.
  • 15. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92:529-34.
  • 16. Kliegman RM, Walsh MC. Neonatal necrotizing enterocolitis: Pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr. 1987;17:213-88.
  • 17. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991-9
  • 18. Erdemir G, Kultursay N, Calkavur S, Zekioğlu O, Koroglu OA, Cakmak B, Yalaz M, Akisu M, Sagol S. Histological chorioamnionitis: Effects on premature delivery and neonatal prognosis. Pediatr Neonatol. 2013;54:267-74.
  • 19. Khong TY, Mooney EE, Ariel I, Balmus NC, Boyd TK, Brundler MA, Derricott H, Evans MJ, Faye-Petersen OM, Gillan JE, Heazell AE, Heller DS, Jacques SM, Keating S, Kelehan P, Maes A, McKay EM, Morgan TK, Nikkels PG, Parks WT, Redline RW, Scheimberg I, Schoots MH, Sebire NJ, Timmer A, Turowski G, van der Voorn JP, van Lijnschoten I, Gordijn SJ. Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group Consensus Statement. Arch Pathol Lab Med. 2016;140:698-713.
  • 20. Lepais L, Gaillot-Durand L, Boutitie F, Lebreton F, Buffin R, Huissoud C, Massardier J, Guibaud L, Devouassoux-Shisheboran M, Allias F. Fetal thrombotic vasculopathy is associated with thromboembolic events and adverse perinatal outcome but not with neurologic complications: A retrospective cohort study of 54 cases with a 3-year follow-up of children Placenta. 2014;35:611-7.
  • 21. Leistra-Leistra MJ, Timmer A, van Spronsen FJ, Geven WB, van der Meer J, Erwich JJ. Fetal thrombotic vasculopathy in the placenta: A thrombophilic connection between pregnancy complications and neonatal thrombosis? Placenta. 2004;25 Suppl A:S102-5.
  • 22. Aouache R, Biquard L, Vaiman D, Miralles F. Oxidative stress in preeclampsia and placental diseases. Int J Mol Sci. 2018;19. pii: E1496.
  • 23. Ganer Herman H, Barber E, Gasnier R, Gindes L, Bar J, Schreiber L, Kovo M. Placental pathology and neonatal outcome in small for gestational age pregnancies with and without abnormal umbilical artery Doppler flow. Eur J Obstet Gynecol Reprod Biol. 2018;222:52-6.
  • 24. Wright E, Audette MC, Ye XY, Keating S, Hoffman B, Lye SJ, Shah PS, Kingdom JC. Maternal vascular malperfusion and adverse perinatal outcomes in low-risk nulliparous women. Obstet Gynecol. 2017;130:1112-20.
  • 25. Weiner E, Feldstein O, Tamayev L, Grinstein E, Barber E, Bar J, Schreiber L, Kovo M. Placental histopathological lesions in correlation with neonatal outcome in preeclampsia with and without severe features. Pregnancy Hypertens. 2018;12:6-10.
  • 26. Francis F, Bhat V, Mondal N, Adhisivam B, Jacob S, Dorairajan G, Harish BN. Fetal inflammatory response syndrome (FIRS) and outcome of preterm neonates - a prospective analytical study. J Matern Fetal Neonatal Med. 2017:1-5.
  • 27. Ocheke AN, Ocheke IE, Agaba PA, Imadde GE, Silas OA, Ajetunmobi OI, Godwins EJ, Ekere C, Sendeht A, Bitrus J, Agaba EI, Sagay AS. Maternal and neonatal outcomes of histological chorioamnionitis. J West Afr Coll Surg. 2016;6:1-14.
  • 28. Kim SY, Choi CW, Jung E, Lee J, Lee JA, Kim H, Kim EK, Kim HS, Kim BI, Choi JH. Neonatal morbidities associated with histologic chorioamnionitis defined based on the site and extent of inflammation in very low birth weight infants. J Korean Med Sci. 2015;30:1476-82.
  • 29. Faye-Petersen OM. The placenta in preterm birth. J Clin Pathol. 2008;61:1261-75. 30. Parry S, Strauss JF 3rd. Premature rupture of the fetal membranes. N Engl J Med. 1998;338:663-70.
  • 31. Lahra MM, Jeffery HE. A fetal response to chorioamnionitis is associated with early survival after preterm birth. Am J Obstet Gynecol. 2004;190:147-51.
  • 32. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol. 1993;81:941-8.
  • 33. Saini S, Goel N, Sharma M, Arora B, Garg N. C-reactive proteins as an indicator of sub-clinical infection in cases of premature rupture of membranes. Indian J Pathol Microbiol. 2003;46:515-6.
  • 34. Musilova I, Andrys C, Drahosova M, Zednikova B, Hornychova H, Pliskova L, Zemlickova H, Jacobsson B, Kacerovsky M. Late preterm prelabor rupture of fetal membranes: Fetal inflammatory response and neonatal outcome. Pediatr Res. 2018;83:630-7.
  • 35. Been JV, Degraeuwe PL, Kramer BW, Zimmermann LJ. Antenatal steroids and neonatal outcome after chorioamnionitis: A meta- analysis. BJOG. 2011;118:113-22.
  • 36. Downes KL, Shenassa ED, Grantz KL. Neonatal outcomes associated with placental abruption. Am J Epidemiol. 2017;186:1319-28.
  • 37. Park CW, Park JS, Jun JK, Yoon BH. Mild to moderate, but not minimal or severe, acute histologic chorioamnionitis or intra-amniotic inflammation is associated with a decrease in respiratory distress syndrome of preterm newborns without fetal growth restriction. Neonatology. 2015;108:115-23.
  • 38. Mousavi AS, Hashemi N, Kashanian M, Sheikhansari N, Bordbar A, Parashi S. Comparison between maternal and neonatal outcome of PPROM in the cases of amniotic fluid index (AFI) of more and less than 5 cm. J Obstet Gynaecol. 2018;38:611-5.
  • 39. Choi CW, Kim BI, Joung KE, Lee JA, Lee YK, Kim EK, Kim HS, Park JD, Choi JH. Decreased expression of transforming growth factor-beta1 in bronchoalveolar lavage cells of preterm infants with maternal chorioamnionitis. J Korean Med Sci. 2008;23:609- 15.
  • 40. Torchin H, Lorthe E, Goffinet F, Kayem G, Subtil D, Truffert P, Devisme L, Benhammou V, Jarreau PH, Ancel PY. Histologic chorioamnionitis and bronchopulmonary dysplasia in preterm infants: The epidemiologic study on low gestational ages 2 cohort. J Pediatr. 2017;187:98-104.e3.
  • 41. Dessardo NS, Mustać E, Dessardo S, Banac S, Peter B, Finderle A, Marić M, Haller H. Chorioamnionitis and chronic lung disease of prematurity: A path analysis of causality. Am J Perinatol. 2012;29:133-40.
  • 42. Durrmeyer X, Kayem G, SinicoM, Dassieu G, Danan C, Decobert F. Perinatal risk factors for bronchopulmonary dysplasia in extremely low gestational age infants: A pregnancy disorder- based approach. J Pediatr. 2012;160:578-83, e2.
  • 43. Redline RW, Wilson-Costello D, Hack M. Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res. 2002;52:713-9.
  • 44. Kent A, Dahlstrom JE. Chorioamnionitis/funisitis and the development of bronchopulmonary dysplasia. J Paediatr Child Health .2004;40:356-9.
  • 45. Dammann O, Brinkhaus MJ, Bartels DB, Dördelmann M, Dressler F, Kerk J, Dörk T, Dammann CE. Immaturity, perinatal inflammation, and retinopathy of prematurity: A multi-hit hypothesis. Early Hum Dev. 2009;85:325-9.
  • 46. Trembath A, Laughon MM. Predictors of bronchopulmonary dysplasia. Clin Perinatol. 2012;39:585-601.
  • 47. Park HW, Choi YS, Kim KS, Kim SN. Chorioamnionitis and patent ductus arteriosus: A systematic review and meta-analysis. PLoS One. 2015;10:e0138114.
  • 48. Mehta R, Nanjundaswamy S, Shen-Schwarz S, Petrova A. Neonatal morbidity and placental pathology. Indian J Pediatr. 2006;73:25-8.
APA CAKIR U, YILDIZ D, Kahvecioğlu D, Okulu E, ALAN S, ERDEVE O, OKCU HEPER A, ATASAY F, ARSAN S (2019). Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant. , 28 - 35. 10.5146/tjpath.2018.01443
Chicago CAKIR Ufuk,YILDIZ DURAN,Kahvecioğlu Dilek,Okulu Emel,ALAN Serdar,ERDEVE OMER,OKCU HEPER Aylin,ATASAY FATMA BEGÜM,ARSAN Saadet Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant. (2019): 28 - 35. 10.5146/tjpath.2018.01443
MLA CAKIR Ufuk,YILDIZ DURAN,Kahvecioğlu Dilek,Okulu Emel,ALAN Serdar,ERDEVE OMER,OKCU HEPER Aylin,ATASAY FATMA BEGÜM,ARSAN Saadet Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant. , 2019, ss.28 - 35. 10.5146/tjpath.2018.01443
AMA CAKIR U,YILDIZ D,Kahvecioğlu D,Okulu E,ALAN S,ERDEVE O,OKCU HEPER A,ATASAY F,ARSAN S Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant. . 2019; 28 - 35. 10.5146/tjpath.2018.01443
Vancouver CAKIR U,YILDIZ D,Kahvecioğlu D,Okulu E,ALAN S,ERDEVE O,OKCU HEPER A,ATASAY F,ARSAN S Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant. . 2019; 28 - 35. 10.5146/tjpath.2018.01443
IEEE CAKIR U,YILDIZ D,Kahvecioğlu D,Okulu E,ALAN S,ERDEVE O,OKCU HEPER A,ATASAY F,ARSAN S "Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant." , ss.28 - 35, 2019. 10.5146/tjpath.2018.01443
ISNAD CAKIR, Ufuk vd. "Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant". (2019), 28-35. https://doi.org/10.5146/tjpath.2018.01443
APA CAKIR U, YILDIZ D, Kahvecioğlu D, Okulu E, ALAN S, ERDEVE O, OKCU HEPER A, ATASAY F, ARSAN S (2019). Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant. Türk Patoloji Dergisi, 35(1), 28 - 35. 10.5146/tjpath.2018.01443
Chicago CAKIR Ufuk,YILDIZ DURAN,Kahvecioğlu Dilek,Okulu Emel,ALAN Serdar,ERDEVE OMER,OKCU HEPER Aylin,ATASAY FATMA BEGÜM,ARSAN Saadet Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant. Türk Patoloji Dergisi 35, no.1 (2019): 28 - 35. 10.5146/tjpath.2018.01443
MLA CAKIR Ufuk,YILDIZ DURAN,Kahvecioğlu Dilek,Okulu Emel,ALAN Serdar,ERDEVE OMER,OKCU HEPER Aylin,ATASAY FATMA BEGÜM,ARSAN Saadet Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant. Türk Patoloji Dergisi, vol.35, no.1, 2019, ss.28 - 35. 10.5146/tjpath.2018.01443
AMA CAKIR U,YILDIZ D,Kahvecioğlu D,Okulu E,ALAN S,ERDEVE O,OKCU HEPER A,ATASAY F,ARSAN S Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant. Türk Patoloji Dergisi. 2019; 35(1): 28 - 35. 10.5146/tjpath.2018.01443
Vancouver CAKIR U,YILDIZ D,Kahvecioğlu D,Okulu E,ALAN S,ERDEVE O,OKCU HEPER A,ATASAY F,ARSAN S Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant. Türk Patoloji Dergisi. 2019; 35(1): 28 - 35. 10.5146/tjpath.2018.01443
IEEE CAKIR U,YILDIZ D,Kahvecioğlu D,Okulu E,ALAN S,ERDEVE O,OKCU HEPER A,ATASAY F,ARSAN S "Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant." Türk Patoloji Dergisi, 35, ss.28 - 35, 2019. 10.5146/tjpath.2018.01443
ISNAD CAKIR, Ufuk vd. "Placenta, Secret Witness of Infant Morbidities: The Relationship Between Placental Histology and Outcome of the Premature Infant". Türk Patoloji Dergisi 35/1 (2019), 28-35. https://doi.org/10.5146/tjpath.2018.01443